Schäffer, Lauge

Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide

Lau, J., Bloch, P., Schäffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L. B., McGuire, J., Steensgaard, D. B., et al. (2015) · Journal of Medicinal Chemistry

Diabetes Treatment and ManagementChemical Synthesis and Analysis

Cited by 1,105

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 961

Real-time trafficking and signaling of the glucagon-like peptide-1 receptor

Roed, S. N., Wismann, P., Underwood, C. R., Kulahin, N., Iversen, H., Cappelen, K. A., Schäffer, L., Lehtonen, J., Hecksher-Soerensen, J., Secher, A., et al. (2014) · Molecular and Cellular Endocrinology

Receptor Mechanisms and SignalingDiabetes Treatment and Management

Cited by 153

Development of Cagrilintide, a Long-Acting Amylin Analogue

Kruse, T., Hansen, J. L., Dahl, K., Schäffer, L., Sensfuss, U., Poulsen, C., Schlein, M., Hansen, A. M. K., Jeppesen, C. B., Dornonville de la Cour, C., et al. (2021) · Journal of Medicinal Chemistry

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 129